There facebook post
We’re pleased to announce the successful enrolment of 40 out of 60 patients in our IRB approved clinical trial for diabetic nerve pain.The multi-arm, head-to-head trial will evaluate the efficacy and tolerability of our proprietary medicinal cannabis product against a multi-billion dollar big pharmaceutical company drug.Half of all people with diabetes will develop neuropathy which can be incredibly challenging and impact a person’s quality of life. We expect to complete trial enrolment and provide a trial read out in Q4 2022.Read more: http://ow.ly/OY8x50KJMXK
- Forums
- ASX - By Stock
- ZLD
- Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled
Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled, page-5
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
70.0¢ |
Change
-0.020(2.78%) |
Mkt cap ! $8.169M |
Open | High | Low | Value | Volume |
71.0¢ | 73.5¢ | 70.0¢ | $3.313K | 4.725K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10393 | 70.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 466 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43 | 0.705 |
2 | 10735 | 0.700 |
2 | 2145 | 0.690 |
2 | 1668 | 0.680 |
2 | 11910 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 466 | 1 |
0.940 | 40000 | 1 |
0.950 | 1429 | 1 |
0.980 | 1021 | 2 |
1.000 | 571 | 1 |
Last trade - 13.03pm 07/10/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |